Wolfgang Miesbach: Award-Winning Poster on Long-Term AAV Gene Therapy Outcomes in Hemophilia B
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Delighted that this poster by Ulrike Reiss was awarded the first poster prize at EAHAD 2026 in Dublin. ‘9‑year outcomes of scAAV2/8‑LP1‑hFIXco enriched for full AAV capsids in adults with severe haemophilia B (PO041)’.
The study builds on the pioneering UCL/St Jude AAV8 haemophilia B programme, comparing a new vector prep enriched for full AAV capsids (full:empty 1:3) with the original 1:10 preparation to see whether this strategy improves FIX expression or liver safety over the long term:
FIX activity rose in the higher‑dose cohort, confirming robust liver transduction, but levels gradually declined over time instead of remaining fully stable.
Rates and patterns of vector‑associated transaminitis were similar to the earlier 1:10 study, suggesting that full‑capsid enrichment alone does not mitigate this immunogenicity signal.
Across 9 years of follow‑up there were no FIX inhibitors, no thrombotic complications and no late liver toxicity, reinforcing the long‑term safety of systemic AAV‑mediated FIX gene transfer in this cohort.
Overall, there was no clear advantage of the 1:3 full‑capsid preparation in terms of reducing transaminitis, enhancing transduction, or stabilising FIX expression compared with the original vector batch.
For me, this award‑winning poster is a great example of how meticulous vector characterisation plus truly long‑term clinical follow‑up can refine our understanding of AAV biology and guide the next generation of safer, more durablegene therapies for haemophilia B”
Stay updated with Hemostasis Today.
-
May 22, 2026, 17:30Veronica Sanchez: Do You Live with Pain after a Stroke?
-
May 22, 2026, 17:25Maxime Dely: A Simple but Powerful Indicator of Platelet Quality
-
May 22, 2026, 17:24Jim Hoffman: A New Approach to Balancing Host Defense and Tissue Protection
-
May 22, 2026, 17:22Lucia Rugeri: Advancing Multidisciplinary Care for Heavy Menstrual Bleeding in Women with Bleeding Disorders
-
May 22, 2026, 17:20Nour Al-Mozain: Optimizing PBSC Collection Through Real-Time CD34+ Monitoring
-
May 22, 2026, 16:30Buse Bor: New Publication on Therapeutic Interventions for Women with Obstetric APS
-
May 22, 2026, 16:29Danny Hsu: The Reversal Dilemma – Rethinking our approach to DOAC-associated ICH
-
May 22, 2026, 16:28Bartosz Hudzik: High Bleeding Risk Does Not Always Mean Bleeding-Risk Predominance
-
May 22, 2026, 16:26Sandeep De: Omicron COVID Infections Linked to Coronary Thrombosis without Detectable Plaque